Mast cells-derived exosomes worsen the development of experimental cerebral malaria

Kunhua Huang1, Li Huang1, Xin Zhang1

  • 1Guangdong Provincial Key Laboratory of Pharmaceutical Bioactive Substances, School of Life Sciences and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou 510006, P. R. China.

Acta Tropica
|September 25, 2021
PubMed

Insights

Mast cells (MCs) release exosomes (MCs-Exo) that worsen experimental cerebral malaria (ECM) by damaging the brain and blood-brain barrier. This study reveals MCs-Exo as a key factor in ECM pathogenesis.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Cerebral malaria (CM) is a severe neurological complication of Plasmodium falciparum infection.
  • Mast cells (MCs) and their mediators are implicated in malaria severity.
  • MCs-derived exosomes (MCs-Exo) are potential mediators, but their role in CM is unclear.

Purpose of the Study:

  • To investigate the role of MCs-Exo in the pathogenesis of experimental cerebral malaria (ECM).
  • To elucidate the mechanisms by which MCs-Exo affect ECM development.

Main Methods:

  • Utilized an experimental CM (ECM) mouse model infected with P. berghei ANKA.
  • Administered MCs-Exo intravenously (i.v.) to infected mice.
  • Employed an in vitro model using bEnd.3 brain microvascular endothelial cells co-cultured with Plasmodium antigen.

Main Results:

  • MCs-Exo injection exacerbated ECM incidence, liver/brain histopathology, and blood-brain barrier breakdown in mice.
  • MCs-Exo promoted Th1 cytokine response and aggravated brain vascular endothelial activation.
  • In vitro, MCs-Exo decreased endothelial cell viability and tight junction protein expression while increasing inflammatory markers.

Conclusions:

  • MCs-Exo significantly worsen the pathogenesis of experimental cerebral malaria in mice.
  • MCs-Exo contribute to ECM by disrupting the blood-brain barrier and promoting neuroinflammation.